Etoposide clinical trials
Also written VP-16, VePesid, VP-16-213 and Toposar.
Includes 23 studies of Etoposide phosphate.
Related medicines add 3 studies
Counted the way a researcher would: Etoposide with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.
This browser remembers your choice.
How each study uses Etoposide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Etoposide studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 10 Nov 1983 · VEPESID · NDA 018768 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
591 studies that test it; most in 2010 (27); 1 more planned to start later
| Year | Studies |
|---|---|
| 1990 | 3 |
| 1991 | 4 |
| 1992 | 2 |
| 1993 | 8 |
| 1994 | 10 |
| 1995 | 7 |
| 1996 | 13 |
| 1997 | 8 |
| 1998 | 23 |
| 1999 | 15 |
| 2000 | 26 |
| 2001 | 18 |
| 2002 | 17 |
| 2003 | 22 |
| 2004 | 21 |
| 2005 | 20 |
| 2006 | 20 |
| 2007 | 26 |
| 2008 | 19 |
| 2009 | 20 |
| 2010 | 27 |
| 2011 | 16 |
| 2012 | 15 |
| 2013 | 24 |
| 2014 | 17 |
| 2015 | 22 |
| 2016 | 20 |
| 2017 | 26 |
| 2018 | 18 |
| 2019 | 13 |
| 2020 | 14 |
| 2021 | 21 |
| 2022 | 12 |
| 2023 | 13 |
| 2024 | 10 |
| 2025 | 12 |
| 2026 | 9 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 27 · Other 571
Children's Oncology Group (45) · National Cancer Institute (NCI) (32) · St. Jude Children's Research Hospital (23) · M.D. Anderson Cancer Center (21) · City of Hope Medical Center (20) · Memorial Sloan Kettering Cancer Center (16) · Alliance for Clinical Trials in Oncology (14) · University of Washington (13)
Often tested with
Tested in the same studies.
Cyclophosphamide (203) · Carboplatin (154) · Cisplatin (129) · Vincristine (107) · Cytarabine (102) · Doxorubicin (98) · Ifosfamide (96) · Melphalan (62)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Tested against it · 14 phase 3 studies under way
Etoposide is the comparator. A study of two new drugs counts under both.
- 3Paclitaxel · Beihua Kong, Weiguo Lv
- 2Carboplatin · Beihua Kong
- 1Datopotamab deruxtecan · AstraZeneca
- 1Rilvegostomig · AstraZeneca
- 1Odronextamab · Regeneron Pharmaceuticals · next primary completion May 2028
- 1Axicabtagene ciloleucel · Kite, A Gilead Company · next primary completion Mar 2031
- 1Vebreltinib · Beijing Pearl Biotechnology Limited Liability Company
- 1QLC5508 · Qilu Pharmaceutical Co., Ltd. · next primary completion Mar 2029
Reaching primary completion within a year · 33, 8 in phase 3
Studies that test Etoposide, phase 3 first.
- Nov 2026High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)Phase 3 · Gustave Roussy, Cancer Campus, Grand Paris
- Dec 2026Comparison Study of EAP and CG Regimens for Mobilizing Hematopoietic Stem Cells in Multiple Myeloma PatientsPhase 3 · The Affiliated People's Hospital of Ningbo University
- Dec 2026Paediatric Hepatic International Tumour TrialPhase 3 · University of Birmingham
- Dec 2026Capizzi Escalating Methotrexate Versus High Dose Methotrexate in Children With Newly Diagnosed T-cell Lymphoblastic Lymphoma (T-LBL)Phase 3 · Children's Cancer Group, China
- Dec 2026First Line Chemotherapy for Classical Hodgkin Lymphoma in Russia (HL-Russia-1)Phase 3 · State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia
- Jun 2027Nivolumab in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell LymphomaPhase 3 · National Cancer Institute (NCI)
- Jun 2027Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell TumorsPhase 3 · Children's Oncology Group
- Sep 2027Adjuvant Chemotherapy of Three-step Regimen in BRCA1/2 Wide Type Ovarian Cancer (ACTS-2)Phase 3 · Fudan University
- Dec 2026Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified ChemotherapyPhase 2 · St. Jude Children's Research Hospital
- Dec 2026Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHLPhase 2 · New York Medical College
Studies
Open first, then newest update. How each study uses Etoposide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 598
- A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and NivolumabRecruitingPhase 3National Cancer Institute (NCI)NCT05675410Written as Etoposide
- DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard ChemoimmunotherapyRecruitingPhase 3Boehringer IngelheimNCT07472517Written as etoposide
- Thiotepa + TBI + Fludarabine + Etoposide for Allo-HSCT in Patients With R/R or High-risk Acute LeukemiaEnrolling by invitationPhase 2Guangdong Second Provincial General HospitalNCT07920796Written as Etoposide
- Auto Stem Cell Transplant for Lymphoma PatientsRecruitingPhase 2Masonic Cancer Center, University of MinnesotaNCT03125642Written as Etoposide
- Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain CancerRecruitingPhase 1Theodore S. JohnsonNCT05106296Written as Etoposide
- Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHLRecruitingPhase 2New York Medical CollegeNCT02393157Written as Etoposide
- Epcoritamab With Dose Adjusted Etoposide, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone and Rituximab (EPOCH-R) for the Treatment of Aggressive B-Cell Non-Hodgkin LymphomaRecruitingPhase 2University of WashingtonNCT07097363Written as Etoposide
- Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic LeukemiaRecruitingPhase 2Mayo ClinicNCT03418038Written as Etoposide
- Metastatic Ewing's Trial Testing Schedule Enhancement to Improve OutcomesRecruitingPhase 1H. Lee Moffitt Cancer Center and Research InstituteNCT07194044Written as Etoposide
- Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed MedulloblastomaRecruitingPhase 2St. Jude Children's Research HospitalNCT05535166Written as Etoposide
- Clinical Trial for Safety and Effectiveness Evaluation of Tarlatamab (AMG757) With Etoposide, Carboplatin and Atezolizumab in Transformed Small Cell Lung Cancer Patients From Adenocarcinoma After EGFR TKI TreatmentRecruitingPhase 2Sehhoon ParkNCT06830694Written as Atezolizumab, Etoposide, Carboplatin, Tarlatamab
- Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic LeukaemiaRecruitingPhase 2/3St. Anna KinderkrebsforschungNCT01949129Written as VP16
- Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell TumoursRecruitingPhase 3University of SydneyNCT02582697Written as Etoposide
- N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With NeuroblastomaRecruitingPhase 2Memorial Sloan Kettering Cancer CenterNCT06528496Written as Etoposide
- A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)RecruitingPhase 3Children's Oncology GroupNCT06401330Written as Etoposide
- Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell TumorsRecruitingPhase 3Children's Oncology GroupNCT03067181Written as Etoposide
- UPDATE AML: UPdated Disease Monitoring And Treatment for Enhanced Outcomes for Pediatric AMLRecruitingEarly Phase 1Baylor College of MedicineNCT07059975Written as Etoposide
- Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/LymphomaRecruitingEarly Phase 1New York Medical CollegeNCT03719105Written as Etoposide
- Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/LeukemiaRecruitingPhase 2M.D. Anderson Cancer CenterNCT03136146Written as Etoposide
- Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA StudyRecruitingPhase 2University of WashingtonNCT06039371Written as Etoposide
See all 598 studies that test Etoposide →
Given beside what is tested · 529 — Etoposide is usual care or a partner of the new treatment
- A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and ToxicityRecruitingPhase 2National Cancer Institute (NCI)NCT06406465Written as Etoposide
- Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)RecruitingPhase 1National Cancer Institute (NCI)NCT04301076Written as Etoposide
- Testing the Safety and Efficacy of the Addition of a New Anti-cancer Drug, ZEN003694, to Chemotherapy Treatment (Cisplatin and Etoposide or Carboplatin and Paclitaxel) for Adult and Pediatric Patients (12-17 Years) With NUT CarcinomaRecruitingPhase 1/2National Cancer Institute (NCI)NCT05019716Written as Etoposide
- Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the LungRecruitingPhase 2/3National Cancer Institute (NCI)NCT05058651Written as Etoposide
- BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)RecruitingPhase 3SystImmune Inc.NCT07625644Written as Carboplatin+ Etoposide + Atezolizumab followed by Atezolizumab and Lurbinectedin
- A Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).RecruitingPhase 3Bristol-Myers SquibbNCT06646276Written as Etoposide
- DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard ChemotherapyRecruitingPhase 3Boehringer IngelheimNCT07544654Written as Etoposide
- A Study to Test Obrixtamig in Combination With Pumitamig in People With Advanced Small Cell Lung Cancer (Dareon®-Rosetta35)RecruitingPhase 1/2Boehringer IngelheimNCT07843940Written as Etoposide
- MOnaliZumab in Combination With durvAlumab (MEDI4736) for tRreatmenT of Small Cell Lung CancerRecruitingPhase 2Khalil ChoucairNCT05903092Written as Etoposide
- A Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin LymphomaRecruitingPhase 1/2Hoffmann-La RocheNCT05533775Written as Etoposide
- Molecularly Stratified Trial for Newly Diagnosed Infant-Type Hemispheric GliomaNot yet recruitingPhase 2St. Jude Children's Research HospitalNCT07916389Written as Etoposide
- Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS TumorsRecruitingPhase 2St. Jude Children's Research HospitalNCT06528691Written as Etoposide
- Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell LymphomaRecruitingPhase 2Alliance for Clinical Trials in OncologyNCT04803201Written as Etoposide
- Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post ConsolidationRecruitingEarly Phase 1C17 CouncilNCT06942039Written as Etoposide
- Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk NeuroblastomaRecruitingPhase 3National Cancer Institute (NCI)NCT06172296Written as Etoposide
- A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic LymphomaRecruitingEarly Phase 1AIDS Malignancy ConsortiumNCT04139304Written as Etoposide
- Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk NeuroblastomaRecruitingPhase 2Masonic Cancer Center, University of MinnesotaNCT02605421Written as Etoposide
- A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung CancerRecruitingPhase 2AbbVieNCT07155174Written as Etoposide
- Paclitaxel-Bleomycin/Etoposide/Cisplatin vs Bleomycin/Etoposide/Cisplatin in Poor-prognosis Non-seminomatous Germ Cell Tumors (NSGCT) and Unfavorable Tumor Marker DeclineRecruitingPhase 2Blokhin's Russian Cancer Research CenterNCT07847190Written as Etoposide
- A Trial of LBL-024 Combined With Platinum-based Chemotherapy for the Treatment of Advanced EP-NECNot yet recruitingPhase 3Nanjing Leads Biolabs Co.,LtdNCT07720193Written as Etoposide injection
Showing 20 of 529.
As the comparator · 44 — what is tested is compared with Etoposide
- A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)RecruitingPhase 1/2Merck Sharp & Dohme LLCNCT07227597Written as Etoposide
- Tamoxifen Versus Etoposide After First Recurrence in GBM PatientsRecruitingPhase 2AHS Cancer Control AlbertaNCT04765098Written as Etoposide
- A Study Comparing QLC5508 in Combination With QL2107 Versus Tislelizumab Plus Platinum-based Chemotherapy in Participants Wih Treatment-naïve Extensive-Stage Small Cell Lung CancerRecruitingPhase 3Qilu Pharmaceutical Co., Ltd.NCT07802821Written as Etoposide
- A Study Comparing BL-B01D1 Combined With Tislelizumab Versus Platinum-containing Chemotherapy Combined With Tislelizumab as First-line Treatment in Patients With Extensive-stage Small Cell Lung Cancer(PANKU-Lung07)RecruitingPhase 3Sichuan Baili Pharmaceutical Co., Ltd.NCT07502300Written as Etoposide
- A Study of YL201 in Combination With Serplulimab in Participants With Treatment-naïve Extensive-stage Small Cell Lung CancerRecruitingPhase 3MediLink Therapeutics (Suzhou) Co., Ltd.NCT07739758Written as Etoposide
- Study Comparing BEBT-908 Combined With R to SOC for the Treatment of Relapsed/Refractory Diffuse Large B-Cell LymphomaRecruitingPhase 3BeBetter Med IncNCT06792253Written as Etoposide Injection
- Teniposide, Cisplatin and Serplulimab for Treatment of ES-SCLC, a Randomized Controlled StudyRecruitingPhase 2Sun Yat-sen UniversityNCT07583511Written as Etoposide
- Irinotecan Liposome (II) or Etoposide Combined With Adebrelimab and Carboplatin in the Treatment of ES-SCLCRecruitingPhase 2Guangzhou Institute of Respiratory DiseaseNCT06739928Written as etoposide combined with adebrelimab and carboplatin
- A Randomized Controlled Study of High-dose Cyclophosphamide Induction Therapy in Adult Patients With HLHRecruitingNot applicableshifeng LouNCT05936086Written as Etoposide
- TC or BEP in Treating Patients With Ovarian Malignant Sex Cord-Stromal TumorsRecruitingPhase 3Beihua KongNCT02429700Written as Etoposide
- TC or BEP in Treating Patients With Malignant Ovarian Germ Cell TumorsRecruitingPhase 3Beihua KongNCT02429687Written as Etoposide
- ChiCGB vs BEAM in High-risk or R/R LymphomasRecruitingPhase 3Sichuan UniversityNCT05466318Written as Etoposide
- Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic TumorRecruitingPhase 3Weiguo LvNCT02639650Written as Etoposide
- Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine CarcinomasActive, not recruitingPhase 2ECOG-ACRIN Cancer Research GroupNCT02595424Written as Etoposide
- A Phase III, Randomised Study of Adjuvant Dato-DXd in Combination With Rilvegostomig or Rilvegostomig Monotherapy Versus Standard of Care, Following Complete Tumour Resection, in Participants With Stage I Adenocarcinoma NSCLC Who Are ctDNA-positive or Have High-risk Pathological FeaturesActive, not recruitingPhase 3AstraZenecaNCT06564844Written as Etoposide
- A Study of ASP2215 Versus Salvage Chemotherapy In Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase 3 (FLT3) MutationCompletedPhase 3Astellas Pharma IncNCT03182244Written as Etoposide
- Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell TumorsActive, not recruitingPhase 2Memorial Sloan Kettering Cancer CenterNCT01873326Written as Etoposide
- Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and AdolescentsActive, not recruitingPhase 3Dana-Farber Cancer InstituteNCT03020030Written as ETOPOSIDE
- A Trial to Learn How Effective and Safe Odronextamab is Compared to Standard of Care for Adult Participants With Previously Treated Aggressive B-cell Non-Hodgkin LymphomaActive, not recruitingPhase 3Regeneron PharmaceuticalsNCT06230224Written as Etoposide
- Carboplatin/Cisplatin + Etoposide + Benmelstobart Sequential Benmelstobart Combined With Anlotinib Versus Carboplatin/Cisplatin + Etoposide + Tislelizumab Sequential Tislelizumab in the Treatment of Extensive Stage Small Cell Lung CancerTerminatedPhase 2Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT06897579Written as Carboplatin for injection/cisplatin for injection + etoposide injection + benmelstobart injection + Anlotinib hydrochloride capsule
Showing 20 of 44.
What changed recently
From the registry's own updates since Oct 18, 2026.
Newly registered1
Codes
What other systems call Etoposide · ClinicalTrials.gg INT007464
- MeSH (NLM) D005047EtoposideConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 6PLQ3CP4P3ETOPOSIDEConfirmed FDA, NLM, Wikidata
- RxNorm 4179Confirmed FDA, Wikidata
- Wikidata Q418817etoposideConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C491EtoposideOne source FDA
- DrugBank DB00773One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D005047 | Etoposide | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 6PLQ3CP4P3 | ETOPOSIDE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 4179 | — | Confirmed FDA, Wikidata |
| Wikidata | Q418817 | etoposide | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C491 | Etoposide | One source FDA |
| DrugBank | DB00773 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.